Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Ultragenyx Pharmaceutical Inc. (RARE)

Income Statement Business | Product

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues:  
    North America     45.3    
    United States      2.3   
    Collaboration and License     41.72.1   
Total revenues  351.4271.0103.751.52.60.10.00.0
            Revenue growth   [+]29.7%161.3%101.4%1871.5%1863.9%   
Cost of goods sold  0.00.00.01.10.00.00.00.0
Gross profit  351.4271.0103.750.32.60.10.00.0
            Gross margin  100.0%100.0%100.0%97.8%100.0%100.0%  
Selling, general and administrative   [+]   127.799.964.933.010.8
Research and development     294.0231.6183.2114.746.0
Other operating expenses  804.2455.4500.5-170.3    
EBITDA   [+]-439.5-172.2-388.3-181.5-323.1-244.6-146.4-56.1
            EBITDA margin  -125.1%-63.5%-374.4%-352.5%-12370.5%-183897.0%  
Depreciation and amortization  13.212.38.519.55.83.41.40.7
EBIT   [+]-452.7-184.4-396.8-201.1-328.9-248.0-147.7-56.8
            EBIT margin  -128.8%-68.0%-382.6%-390.4%-12593.5%-186471.4%  
Non-recurring items   [+]   170.3    
Interest income  1.97.013.29.54.13.82.30.6
Other income (expense), net   [+]-2.2-8.0-15.9164.76.5-1.6-0.2-3.6
Pre-tax income  -453.0-185.4-399.4-197.1-318.3-245.8-145.6-59.8
Income taxes  1.01.23.30.5-16.20.00.00.0
            Tax rate      5.1% 0.0%0.0%
Net income  -454.0-186.6-402.7-197.6-302.1-245.9-145.6-64.6
            Net margin  -129.2%-68.8%-388.3%-383.7%-11567.3%-184867.7%  
   
Basic EPS   [+]($6.70)($3.07)($7.12)($3.97)($7.12)($6.21)($3.96)($2.25)
Diluted EPS   [+]($6.70)($3.07)($7.12)($3.97)($7.12)($6.21)($3.96)($2.25)
   
   
Shares outstanding (basic)   [+]67.860.856.649.842.539.636.828.8
Shares outstanding (diluted)   [+]67.860.856.649.842.539.636.828.8
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy